Testing for residual cancer cells before blood cell transplant therapy is important and practical, new study finds

Testing for residual cancer cells before blood cell transplant therapy is important and practical, new study finds

Patients in remission after battling a high-risk blood cancer are likely to have better outcomes if no trace of the cancer is detectable before the patients receive donor blood cells.

​Medical Xpress – latest medical and health news stories

Read More

Comments

No comments yet. Why don’t you start the discussion?

Leave a Reply

Your email address will not be published. Required fields are marked *